SECORA MICHAEL (CFO & Chief Corp Dev Ofcr) received a stock award from IAMBIC THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/16/2026ACC: 0001855980-26-000007
Officer· CFO & Chief Corp Dev Ofcr
Since Oct 2026
+198.70K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
198.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28.40K
Price / share
—
Trade value
—
% of position
14.9%
10/14/2026
190.16K→218.56K
Total
Net shares
+28.40K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/14/2026 | A · Award | +28.40K | — | — | 14.9% | 190.16K | 218.56K |
| Total | +28.40K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
170.30K shares
Shares
+170.30K
Strike price
16
Held after
170.30K
Exercisable
—
10/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock170.30K shares | 10/14/2026 | A · Award | +170.30K | 16 | — | 170.30K |